Drugs / Gamma-Aminobutyric Acid
Gamma-Aminobutyric Acid
also known as
GABA · .gamma.-amino-n-butyric acid · 4-aminobutyric acid · Aminobutyric acid · Aminobutyric acid, gamma- · Factor i · Gamma-aminobutyrate · NSC-27418 · +1 more
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03635437 | Sep 2018 → Sep 2022 | type 1 diabetes mellitus | Per-Ola Carlsson | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT07477288 | Mar → Sep 2025 | skin atrophy | Hasanuddin University | Completed | No outcome recorded |
| Phase 2 | NCT04683640 | Apr 2021 → May 2024 | chronic pain syndrome | University of Florida | Completed | No outcome recorded |
| Phase 2 | NCT01561508 | Jun 2012 → Apr 2013 | diabetes mellitus | University of Alabama at Birmingham | Withdrawn | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05221892 | Nov 2021 → Mar 2023 | — | Fundação Educacional Serra dos Órgãos | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02928328 | Oct 2016 → Dec 2018 | — | Aalborg University | Unknown | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 1 | NCT02002130 Comparator | Jan 2015 → Oct 2021 | type 1 diabetes mellitus | University of Alabama at Birmingham | Completed | No outcome recorded |
| Phase 4 | NCT04144439 Comparator | Jul 2018 → Dec 2028 expected | epilepsy | Tanta University | Recruiting | No outcome recorded |
| — | NCT01781884 Comparator | Jan 2013 → Dec 2014 | type 1 diabetes mellitus | Huashan Hospital | Unknown | No outcome recorded |
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gamma-Aminobutyric Acid | “Patients will receive the Active GABA (Gamma-Amino Butyric Acid) capsules.” NCT02002130 ↗5“Gamma-Aminobutyric Acid (GABA) 3%” NCT07477288 ↗ |
| Known as | .gamma.-amino-n-butyric acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL96 ↗ |
| Known as | 4-aminobutyric acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL96 ↗ |
| Known as | Aminobutyric acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL96 ↗ |
| Known as | Aminobutyric acid, gamma- | ChEMBL registry synonym — accepted as the source's own label CHEMBL96 ↗ |
| Known as | Factor i | ChEMBL registry synonym — accepted as the source's own label CHEMBL96 ↗ |
| Known as | GABA | “The studied combination drug is composed by GABA (gamma-aminobutyric acid), the main inhibitory neurotransmitter of the central nervous system.” NCT05221892 ↗7“Experimentally, gamma-aminobutyric acid (GABA) has been found to exert immune-modulatory effects and induce beta-cell regeneration” PMID 34635547 ↗ Oct 2021 “You will take, by mouth, 2 pills of GABA (500 mg) (Capsule 250mg) daily at home for 4 weeks” NCT04683640 ↗ “Gamma Aminobutyric Acid (GABA)” NCT01781884 ↗ |
| Known as | Gamma-aminobutyrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL96 ↗ |
| Known as | NSC-27418 | ChEMBL registry synonym — accepted as the source's own label CHEMBL96 ↗ |
| Known as | Vigabatrin impurity, .gamma.-aminobutyric acid- | ChEMBL registry synonym — accepted as the source's own label CHEMBL96 ↗ |
| Modality | Small molecule | — CHEMBL96 ↗ |
| Route | Oral | “gamma-amino butyric acid will be administered orally” NCT01561508 ↗ |